Langerhans cells are not required for efficient skin graft rejection.
about
Distinct functional programs in fetal T and myeloid lineagesEpidermal Langerhans cells are not required for UV-induced immunosuppression.Langerhans cells serve as immunoregulatory cells by activating NKT cells.Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivityRole of immune-regulatory cells in skin pathology.Langerhans cells are not required for graft-versus-host disease.Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis.Epidermal Langerhans cells tune skin reactivity to contact allergens.StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trialEarly immune events in the induction of allergic contact dermatitisThe evolving function of Langerhans cells in adaptive skin immunity.Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in miceInsights into Langerhans cell function from Langerhans cell ablation models.Langerhans cells are not required for the CD8 T cell response to epidermal self-antigensCartilage repair: past and future--lessons for regenerative medicine.A two-step model for Langerhans cell migration to skin-draining LN.Characteristics and functions of murine cutaneous dendritic cells: a synopsis of recent developments.Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis.Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β.Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin.Revisiting the tolerogenicity of epidermal Langerhans cells.Langerhans cells: critical regulators of skin immunity?Harnessing dendritic cells in inflammatory skin diseases.Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.Dendritic cells and their role in periodontal disease.Fundamental immunology of skin transplantation and key strategies for tolerance induction.Dendritic cells in the periphery control antigen-specific natural and induced regulatory T cells.Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.Prevention of Photocarcinogenesis by Agonists of 5-HT1A and Antagonists of 5-HT2A Receptors.Acute ablation of Langerhans cells enhances skin immune responses.Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10.PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.March1-dependent modulation of donor MHC II on CD103 dendritic cells mitigates alloimmunity
P2860
Q26824945-A30400F9-93E2-46FA-9BA6-10904B33A40BQ34063859-06F9D35D-7D6C-4471-892F-68A4E86DDB54Q34179869-75C60CE5-A4BF-485D-81DE-DBBE70826FA1Q34306188-24E1D735-99FD-4014-A3FD-D170835ADAECQ34417553-FD2D77B5-DBAC-422D-A435-8BF159AB3D89Q34542158-CF7DE3A7-EEF3-41D5-AEB5-EBC90B819199Q35137646-930CDBAE-1523-49C3-8A76-F0BA541EBD1AQ35620761-7D961B9F-86B8-4B92-81E0-3BCFEE4CD20BQ35913763-162D83E9-53E2-4D0D-980B-70E914976F1FQ36084801-5A6980FF-8E51-4561-9681-10D433EACB86Q36627450-DDD65A85-1EBF-4389-814C-C35F3B113826Q36627481-4DF88775-F0BA-44FF-81E1-DAD22526F449Q37191348-7C6EDEBB-7B66-479E-BB96-649B8EC151BFQ37268972-5024F316-8B25-4F85-BAED-99AEF60EEEF2Q37294531-BA17496D-38F1-4360-9567-01EF4431C5CCQ37296148-591A23DA-9C2F-4CC4-946E-CB8A4F286A3FQ37320029-6F382244-75D5-4194-9DFD-4AB46309C642Q37349759-695CA55B-F939-499D-AFE8-F1D7C6D53136Q37441857-A19E083E-01A7-435F-8129-253FDF2ACF0DQ37468713-93E22312-4EB3-4D3D-A075-B28C28A1F811Q37700833-9F6FF1F3-E6DE-4147-A97A-AFB839D47AD6Q37704952-DE03119B-12F4-45F2-A637-B1461C90F3FEQ37721150-5A784669-4029-4879-BD79-076247B6BBD4Q37835969-C34C0F23-6718-4114-9232-2A240C4FF3A7Q38076687-57A8E871-BBB5-4DFD-B0C8-D6E9D45A4F36Q38105171-5D7AA651-B859-41ED-85EE-94D9A159690FQ38107791-EBADEA57-78F9-4D76-A22F-5CF51C5343CFQ38117138-1CB2A16E-3C96-49CD-B939-03A2A4F64946Q38183173-515CA763-5A0C-4BA5-BE24-4E67B1E3BFF7Q38318548-4ABD6373-5AC0-4A2A-A1D9-188595CC1B90Q41906344-EA476DB4-2CFF-4E4F-93D8-1713E1347531Q42049743-BA0792F4-A96D-4E40-A858-32D8D127935BQ42230861-3E7D8123-9C83-4351-8C2D-39D404EF7A73Q58699588-73DB92CB-2AA9-4F05-A969-28F8973859CD
P2860
Langerhans cells are not required for efficient skin graft rejection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Langerhans cells are not required for efficient skin graft rejection.
@en
type
label
Langerhans cells are not required for efficient skin graft rejection.
@en
prefLabel
Langerhans cells are not required for efficient skin graft rejection.
@en
P2093
P2860
P356
P1476
Langerhans cells are not required for efficient skin graft rejection.
@en
P2093
Daniel H Kaplan
Daniel L Mueller
Fadi G Lakkis
Jagdeep S Obhrai
Mark J Shlomchik
Martin Oberbarnscheidt
Warren D Shlomchik
P2860
P2888
P304
P356
10.1038/JID.2008.52
P407
P577
2008-03-13T00:00:00Z
P5875
P6179
1050667774